Your browser doesn't support javascript.
loading
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Street, Duncan; Jabbari, Edwin; Costantini, Alyssa; Jones, P Simon; Holland, Negin; Rittman, Timothy; Jensen, Marte T; Chelban, Viorica; Goh, Yen Y; Guo, Tong; Heslegrave, Amanda J; Roncaroli, Federico; Klein, Johannes C; Ansorge, Olaf; Allinson, Kieren S J; Jaunmuktane, Zane; Revesz, Tamas; Warner, Thomas T; Lees, Andrew J; Zetterberg, Henrik; Russell, Lucy L; Bocchetta, Martina; Rohrer, Jonathan D; Burn, David J; Pavese, Nicola; Gerhard, Alexander; Kobylecki, Christopher; Leigh, P Nigel; Church, Alistair; Hu, Michele T M; Houlden, Henry; Morris, Huw; Rowe, James B.
Affiliation
  • Street D; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 OQQ, UK.
  • Jabbari E; Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Costantini A; Movement Disorders Centre, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Jones PS; Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Holland N; Movement Disorders Centre, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Rittman T; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 OQQ, UK.
  • Jensen MT; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 OQQ, UK.
  • Chelban V; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 OQQ, UK.
  • Goh YY; Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Guo T; Movement Disorders Centre, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Heslegrave AJ; Department of Neuromuscular Diseases, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Roncaroli F; Neurobiology and Medical Genetics Laboratory, 'Nicolae Testemitanu' State University of Medicine and Pharmacy, Chisinau 2004, Republic of Moldova.
  • Klein JC; Department of Neuromuscular Diseases, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Ansorge O; Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Allinson KSJ; Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Jaunmuktane Z; UK Dementia Research Institute, University College London, London, W1T 7NF, UK.
  • Revesz T; Geoffrey Jefferson Brain Research Centre, Division of Neuroscience, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M6 8HD, UK.
  • Warner TT; Wellcome Centre for Integrative Neuroimaging, Oxford Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
  • Lees AJ; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
  • Zetterberg H; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX3 9DU, UK.
  • Russell LL; University of Cambridge Department of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, Cambridge, CB2 OQQ, UK.
  • Bocchetta M; Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Rohrer JD; Queen Square Brain Bank for Neurological Disorders, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Burn DJ; Reta Lila Weston Institute, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Pavese N; Queen Square Brain Bank for Neurological Disorders, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Gerhard A; Reta Lila Weston Institute, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Kobylecki C; Queen Square Brain Bank for Neurological Disorders, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Leigh PN; Reta Lila Weston Institute, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Church A; Queen Square Brain Bank for Neurological Disorders, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Hu MTM; Reta Lila Weston Institute, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Houlden H; Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Morris H; UK Dementia Research Institute, University College London, London, W1T 7NF, UK.
  • Rowe JB; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 30 Mölndal, Sweden.
Brain ; 146(8): 3232-3242, 2023 08 01.
Article de En | MEDLINE | ID: mdl-36975168
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Paralysie supranucléaire progressive / Atrophie multisystématisée / Syndromes parkinsoniens Type d'étude: Clinical_trials / Prognostic_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Brain Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Paralysie supranucléaire progressive / Atrophie multisystématisée / Syndromes parkinsoniens Type d'étude: Clinical_trials / Prognostic_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Brain Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni